Patent · US Expired

Polypeptides from Kaposi's sarcoma-associated herpesvirus, DNA encoding same and uses thereof

US5849564A · kind A · utility

13Cited by

0References

12Claims

0Family size

Assignee

The Trustees of Columbia University in the City of New York · US

Inventors

Yuan Chang · New York, US
Roy A. Bohenzky · Mountain View, US
James J. Russo · New York, US
Isidore S. Edelman · New York, US
Patrick S. Moore · New York, US

Key dates

Filing date	Nov 29, 1996
Grant date	Dec 15, 1998
Priority date	—
Expiry date	Nov 29, 2016

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/16422
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

This invention provides an isolated nucleic acid molecule which encodes Kaposi's Sarcoma-Associated Herpesvirus (KSHV) polypeptides. This invention provides an isolated polypeptide molecule of KSHV. This invention provides an antibody specific to the polypeptide. Antisense and triplex oligonucleotide molecules are also provided. This invention provides a vaccine for Kaposi's Sarcoma (KS). This invention provides methods of vaccination, prophylaxis, diagnosis and treatment of a subject with KS and of detecting expression of a DNA virus associated with Kaposi's sarcoma in a cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.